MOSAICO HIV Vaccine Trial

New Orleans LA

Description

First Phase III Preventative HIV Vaccine Trial Mosaico is a large study that will try to prove whether the experimental vaccine regimen can prevent HIV infection. These vaccines have been approved for research purposes only. If Mosaico can show that the study vaccine regimen works, it will be a very important step on the way to finding a safe and effective vaccine for the prevention of HIV.